CT
CERo Therapeutics Holdings, Inc. Common Stock
🇺🇸XNAS.CEROUnited StatesHealthcare
$0.12USDdown -1.68 (-93.33%)ClosedDelayed12:15 AM
Price$0.12-1.68 (-93.33%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US71902K3032
- CUSIP
- Not reported
Company
- Employees
- 8
- Headquarters
- South San Francisco, United States
- Website
- https://www.cero.bio
- CEO
- Mr. Christopher B. Ehrlich M.B.A.
Market
- Shares outstanding
- 71.6M
- Market cap
- $223.82K
Highlights
No 52-week high and low are reported for this listing.
- Market cap
- $223.82K
- EPS LTM
- -$0.39
- P/E LTM
- -0.31calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$16.31M-20.77%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$12.1M-93.87%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.